Bayer Aktiengesellschaft Announces Dividend of $0.02 (OTCMKTS:BAYRY)

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) announced a dividend on Wednesday, April 3rd, NASDAQ reports. Shareholders of record on Tuesday, April 30th will be given a dividend of 0.0191 per share on Monday, May 13th. The ex-dividend date of this dividend is Monday, April 29th.

Bayer Aktiengesellschaft Price Performance

Shares of BAYRY opened at $7.39 on Friday. Bayer Aktiengesellschaft has a 52-week low of $6.96 and a 52-week high of $16.47. The company has a quick ratio of 0.80, a current ratio of 1.27 and a debt-to-equity ratio of 1.15. The stock has a 50 day moving average price of $7.40 and a 200 day moving average price of $8.70.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) last announced its quarterly earnings results on Tuesday, March 5th. The company reported $0.50 EPS for the quarter, beating the consensus estimate of $0.38 by $0.12. The company had revenue of $12.77 billion for the quarter. Bayer Aktiengesellschaft had a negative net margin of 6.31% and a positive return on equity of 17.27%. Equities analysts predict that Bayer Aktiengesellschaft will post 1.36 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on the stock. Sanford C. Bernstein reiterated a “market perform” rating on shares of Bayer Aktiengesellschaft in a research note on Thursday, March 7th. Wolfe Research lowered shares of Bayer Aktiengesellschaft from an “outperform” rating to a “peer perform” rating in a research note on Tuesday, January 30th. Finally, Citigroup restated a “neutral” rating on shares of Bayer Aktiengesellschaft in a research report on Thursday, February 29th. One research analyst has rated the stock with a sell rating and eight have issued a hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold”.

Bayer Aktiengesellschaft Company Profile

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.